Navigation Links
How do neural stem cells decide what to be -- and when?
Date:11/15/2010

SINGAPORE Researchers at Duke-NUS Graduate Medical School in Singapore have uncovered a novel feedback mechanism that controls the delicate balance of brain stem cells.

Zif, a newly discovered protein, controls whether brain stem cells renew themselves as stem cells or differentiate into a dedicated type of neuron (nerve cell).

In preclinical studies, the researchers showed that Zif is important for inhibiting overgrowth of neural stem cells in fruit flies (genus Drosophila) by ensuring that a proliferation factor (known as aPKC) maintains appropriate levels in neural stem cells.

"There is a Zif-related protein in humans, and its function remains to be analyzed," said senior and corresponding author Hongyan Wang, Ph.D. "Our finding has paved the way for future study of this human protein in the context of diseases, including glioblastomas, the most severe form of brain tumors."

She said it may be "possible to manipulate Zif function into a form of therapy against diseases, including cancer."

The study was published in the Nov. 16 issue of Developmental Cell journal.

The findings suggest that a lack of Zif protein expression correlates with neural stem cell overpopulation in Drosophila.

The mechanism is circular: Zif is a transcription factor that inhibits the manufacture of aPKC. But Zif can also be tagged with a phosphate by aPKC, which excludes Zif from the cell nucleus, and leads to Zif inactivation, which in turn means an overgrowth of stem cells.

"Next, we would like to investigate the mechanisms of neural stem cells' self-renewal in mammals, and we are looking for the right collaborators," Wang said. "We will also continue to use Drosophila as a powerful model system to uncover critical players in neural stem cell self-renewal so that we can understand the network involved in this regulation."


'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Page: 1

Related medicine news :

1. Neuralstem updates ALS clinical trial progress
2. Neuralstem chief scientific officer to take part in World Stem Cell Summit plenary session
3. Neuralstem stem cells survive and differentiate into neurons in rats with stroke
4. Misfolded neural proteins linked to autism disorders
5. The neural basis of the depressive self
6. Hurts so good -- neural clues to the calming effects of self-harm
7. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
8. Human neural stem cells restore motor function in mice with chronic spinal cord injury
9. FDA approves first human neural stem cell clinical trial to treat brain tumors
10. Neuralstem updates clinical trial progress
11. Race and empathy matter on neural level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... Falls Church, VA (PRWEB) , ... September 21, ... ... Use Policy , **An FDAnews Management Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the ... every edge they can get while staying in compliance with FDA rules. , ...
(Date:9/21/2017)... WA (PRWEB) , ... September 21, 2017 , ... ... technology using Microscan’s LVS 7510 at the Global GS1 Healthcare Conference 2017 in ... of the life-sciences industry for ensuring label quality and improving patient safety. ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand that ... detail to the athletic wear market with the launch of their FlipBelt Crops. , ... their essentials securely at their fingertips while at the gym, on the trail, or ...
(Date:9/20/2017)... ... September 20, 2017 , ... FirstAlign ( http://www.firstalign.com ), combines ... Artificial Intelligence (AI) thinking, announced today the launch of its revamped web presence. ... information that offers a more comprehensive understanding of the organization’s business and machine ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... and commercialization, has just released a new white paper discussing the benefits ... than ever about medical device, pharmaceutical, and combination product organizations making sure ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... , Sept. 6, 2017   PDI , a ... it will host an educational session focused on the ... infection (CLABSI) prevention at the 2017 Annual Scientific Meeting ... will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
Breaking Medicine Technology: